Phosphorylation of the menin tumor suppressor protein on serine 543 and serine 583

Molecular Cancer Research

Volumn 4, Issue 10, 2006, Pages 793-801

  MacConaill, Laura E ^a,c   Hughes, Christina M ^a,b   Rozenblatt Rosen, Orit ^a,b   Nannepaga, Suraj ^a   Meyerson, Matthew ^a,b,c  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; HISTONE METHYLTRANSFERASE; HOMEOBOX C8 PROTEIN; HOMEODOMAIN PROTEIN; METHIONINE; MIXED LINEAGE LEUKEMIA PROTEIN; PROTEASOME; PROTEIN ASH2L; RETINOBLASTOMA BINDING PROTEIN 5; RNA POLYMERASE II; SERINE; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVITY; ENZYME DEGRADATION; GENE EXPRESSION; HUMAN; HUMAN CELL; MASS SPECTROMETRY; MOUSE; MULTIPLE ENDOCRINE NEOPLASIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; SITE DIRECTED MUTAGENESIS; TUMOR SUPPRESSOR GENE;

CELL DIFFERENTIATION; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; DNA DAMAGE; DNA-BINDING PROTEINS; HISTONE-LYSINE N-METHYLTRANSFERASE; HL-60 CELLS; HOMEODOMAIN PROTEINS; HUMANS; NEOPLASM PROTEINS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS; SERINE; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS;

EID: 33750580647     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-06-0123     Document Type: Article

References (42)

1. Chandrasekharappa SC, Guru SC, Manickam P, et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 1997;276:404-7.
2. Brandi ML, Marx SJ, Aurbach GD, et al. Familial multiple endocrine neoplasia type 1: a new look at pathophysiology. Endocr Rev 1987;8:391-405.
3. Agarwal SK, Kester MB, Debelenko LV, et al. Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states. Hum Mol Genet 1997;6:1169-75.
4. Lemmens I, Van de Ven WJ, Kas K. et al. Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1. Hum Mol Genet 1997;6:1177-83.
5. Mayr B, Apenberg S, Rothamel T, et al. Menin mutations in patients with multiple endocrine neoplasia type 1. Eur J Endocrinol 1997;137:684-7.
6. Bassett JH, Forbes SA, Pannett AA, et al. Characterization of mutations in patients with multiple endocrine neoplasia type 1. Am J Hum Genet 1998;62:232-44.
7. Debelenko LV, Brambilla E, Agarwal SK, et al. Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung. Hum Mol Genet 1997;6:2285-90.
8. Zhuang Z, Ezzat SZ, Vortmeyer AO, et al. Mutations of the MEN1 tumor suppressor gene in pituitary tumors. Cancer Res 1997;57:5446-51.
9. Hessman O, Lindberg D, Skogseid B, et al. Mutation of the multiple endocrine neoplasia type 1 gene in nonfamilial, malignant tumors of the endocrine pancreas. Cancer Res 1998;58:377-9.
10. Jakobovitz-Picard O, Olchovsky D, Berezin M, et al. Mutation analysis of the MEN1 gene in Israeli patients with MEN1 and familial isolated hyperprolactinemia. Hum Mutat 2000;16:269.
11. Crabtree JS, Scacheri PC, Ward JM, et al. A mouse model of multiple endocrine neoplasia, type 1, develops multiple endoerine tumors. Proc Natl Acad Sci U S A 2001;98:1118-23.
12. Bertolino P, Tong WM, Galendo D, et al. Heterozygous Men1 mutant mice develop a range of endocrine tumors mimicking multiple endoerine neoplasia type 1. Mol Endocrinol 2003;17:1880-92.
13. Bertolino P, Radovanovic I, Casse H, et al. Genetic ablation of the tumor suppressor menin causes lethality at mid-gestation with defects in multiple organs. Mech Dev 2003;120:549-60.
14. Bertolino P, Tong WM, Herrera PL, et al. Pancreatic β-cell-specific ablation of the multiple endocrine neoplasia type 1 (MEN1) gene causes full penetrance of insulinoma development in mice. Cancer Res 2003;63:4836-41.
15. Crabtree JS, Scacheri PC, Ward JM, et al. Of mice and MEN1: Insulinomas in a conditional mouse knockout. Mol Cell Biol 2003;23:6075-85.
16. Guru SC, Prasad NB, Shin EJ, et al. Characterization of a MEN1 ortholog from Drosophila melanogaster. Gene 2001;263:31-8.
17. Manickam P, Vogel AM, Agarwal SK, et al. Isolation, characterization, expression and functional analysis of the zebrafish ortholog of MEN 1. Mamm Genome 2000;11:448-54.
18. Maruyama K, Tsukada T, Honda M, et al. Complementary DNA structure and genomic organization of Drosophila menin. Mol Cell Endocrinol 2000;168:135-40.
19. Stewart C, Parente F, Piehl F, et al. Characterization of the mouse Men1 gene and its expression during development. Oncogene 1998;17:2485-93.
20. Karges W, Maier S, Wissmann A, et al. Primary structure, gene expression and chromosomal mapping of rodent homologs of the MEN1 tumor suppressor gene. Biochim Biophys Acta 1999;1446:286-94.
21. Guru SC, Goldsmith PK, Burns AL, et al. Menin, the product of the MEN1 gene, is a nuclear protein. Proc Natl Acad Sci U S A 1998;95:1630-4.
22. Wautot V, Khodaei S, Frappait L, et al. Expression analysis of endogenous menin, the product of the multiple endocrine neoplasia type 1 gene, in cell lines and human tissues. Int J Cancer 2000;85:877-81.
23. Guru SC, Crabtree JS, Brown KD, et al. Isolation, genomic organization, and expression analysis of Men1, the murine homolog of the MEN1 gene. Mamm Genome 1999;10:592-6.
24. Lin SY, Elledge SJ. Multiple tumor suppressor pathways negatively regulate telomerase. Cell 2003;113:881-9.
25. Agarwal SK, Kennedy PA, Scacheri PC, et al. Menin molecular interactions: insights into normal functions and tumorigenesis. Horm Metab Res 2005;37:369-74.
26. Hughes CM, Rozenblatt-Rosen O, Milne TA, et al. Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus. Mol Cell 2004;13:587-97.
27. Yokoyama A, Wang Z, Wysocka J, et al. Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression. Mol Cell Biol 2004;24:5639-49.
28. Yokoyama A, Somervaille TC, Smith KS. et al. The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis. Cell 2005;123:207-18.
29. Chen YX, Yan J, Keeshan K, et al. The tumor suppressor menin regulates hematopoiesis and myeloid transformation by influencing Hox gene expression. Proc Natl Acad Sci U S A 2006;103:1018-23.
30. Milne TA, Hughes CM, Lloyd R, et al. Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors. Proc Natl Acad Sci U S A 2005;102:749-54.
31. Karnik SK, Hughes CM, Gu X, et al. Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27Kip1 and p18INK4c. Proc Natl Acad Sci U S A 2005;102:14659-64.
32. Scacheri PC, Davis S, Odom DT, et al. Genome-wide analysis of menin binding provides insights into MEN1 tumorigenesis. PLoS Genet 2006;2:e51.
33. Thorsness PE, Koshland DE, Jr. Inactivation of isocitrate dehydrogenase by phosphorylation is mediated by the negative charge of the phosphate. J Biol Chem 1987;262:10422-5.
34. Jin S, Mao H, Schnepp RW, et al. Menin associates with FANCD2, a protein involved in repair of DNA damage. Cancer Res 2003;63:4204-10.
35. Sukhodolets KE, Hickman AB, Agarwal SK, et al. The 32-kilodalton subunit of replication protein A interacts with menin, the product of the MEN1 tumor suppressor gene. Mol Cell Biol 2003;23:493-509.
36. Peng J, Gygi SP. Proteomics: the move to mixtures. J Mass Spectrom 2001;36:1083-91.
37. Boyle WJ, van der Geer P, Hunter T. Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates. Methods Enzymol 1991;201:110-49.
38. Kamps MP. Determination of phosphoamino acid composition by acid hydrolysis of protein blotted to Immobilon. Methods Enzymol 1991;201:21-7.
39. Strahl BD, Ohba R, Cook RG, et al. Methylation of histone H3 at lysine 4 is highly conserved and correlates with transcriptionally active nuclei in Tetrahymena. Proc Natl Acad Sci U S A 1999;96:14967-72.
40. Garcia-Higuera I, Taniguchi T, Ganesan S, et al. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol Cell 2001;7:249-62.
41. Vindelov LL, Christensen IJ, Nissen NI. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 1983;3:323-7.
42. Frank SR, Schroeder M, Fernandez P, et al. Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation. Genes Dev 2001;15:2069-82.